Primary Health Properties PLC

Director's Dealing • May 15, 2023

National Storage Mechanism | Additional information

RNS Number : 4092Z

Primary Health Properties PLC

15 May 2023

Primary Health Properties PLC

Director & PDMR dealings

Primary Health Properties PLC (the "Company" or "PHP"), one of the UK's leading investors in modern primary healthcare facilities, announces the following share dealing by a person closely associated with a Person Discharging Managerial Responsibilities ("PDMR's").

The Notification of Dealing Form for each PDMR can be found below.  This notification is made in accordance with the UK Market Abuse Regulation.

1	Details of Person Discharging Managerial Responsibility/person closely associated with them ("PCA")
(a)	Name	Philippa Bateman
2	Reason for the notification
(a)	Position/status	PCA, being the wife of David Bateman, Chief Investment Officer and PDMR
(b)	Initial notification/ amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
(a)	Name of Entity	Primary Health Properties PLC
(b)	Legal Entity Identifier	213800Y5CJHXOATK7X11
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date: and (iv) each place where transactions have been conducted
(a)	Description of the financial instrument	Ordinary shares of 12.5p ISIN: GB00BYRJ5J14
(b)	Nature of the transaction	Purchase
(c)	Aggregated information Price(s) and volume(s)	Price(s)	Volume(s)
£1.046	1,433
(d)	Aggregated volume price	Single transaction £1,499.05
(e)	Date of transaction	12 May 2023
(f)	Place of transaction	London Stock Exchange (xlon)

For further information

Primary Health Properties PLC

Toby Newman, Company Secretary

+44(0) 203 833 3343

Legal Entity Identifier: 213800Y5CJHXOATK7X11

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHGIGDURBBDGXU